Semler Scientific, Inc. (NASDAQ:SMLR) is a company that provides healthcare solutions, primarily focusing on diagnostic and monitoring products. The company is known for its innovative approach in the medical field, offering products that assist in the early detection of diseases. Semler competes with other healthcare technology firms, striving to maintain a strong market presence.
On July 28, 2025, Brett Knoblauch from Cantor Fitzgerald set a price target of $61 for SMLR. At that time, the stock was trading at $38.08, suggesting a potential upside of approximately 60.19%. This optimistic outlook indicates confidence in the company's future performance and potential growth in the healthcare sector.
However, the stock is currently under scrutiny. Rosen Law Firm is investigating potential securities claims on behalf of SMLR shareholders. The investigation is based on allegations that Semler Scientific may have provided misleading business information. This legal action could impact investor confidence and the stock's future performance.
SMLR's stock price reflects a decrease of 2.08%, with a change of $0.81, currently priced at $38.08. During the trading day, the stock fluctuated between a low of $36.18 and a high of $38.50. Over the past year, the stock has experienced significant volatility, with a high of $81.56 and a low of $21.77.
The company's market capitalization is approximately $695.1 million, with a trading volume of 633,348 shares on the NASDAQ exchange. This data highlights the stock's active trading and investor interest, despite the ongoing legal investigation and recent price fluctuations.
